Safety
-
Plasma-Lyte 148 Injection in Plastic Container (includes Plasma-Lyte A Injection pH 7.4) January 2009
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) -- January 2009
| The detailed view includes drug products with safety labeling changes to the BOXED WARNING, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS, or PATIENT PACKAGE INSERT/MEDICATION GUIDE sections. Deletions or editorial revisions made to these sections are not included in this summary. Read about the new physician labeling format. |
PRECAUTIONS/Drug/Laboratory Test interactions
- provides for the addition of Drug/Laboratory Test interactions safety information
-
-
